Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,32 USD | +13,79% | +17,86% | +24,47% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 21,14 mln. 19,77 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -9 mln. -8,42 mln. | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,2
x | K/w-verhouding 2025 * |
-
| Werknemers | 1 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,61% |
Recentste transcriptie over Alaunos Therapeutics, Inc.
1 dag | +13,79% | ||
1 week | +17,86% | ||
Lopende maand | -27,07% | ||
1 maand | -30,16% | ||
3 maanden | -49,91% | ||
6 maanden | -13,56% | ||
Lopend jaar | +24,47% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dale Hogue
CEO | Chief Executive Officer | 54 | 29/12 |
Director of Finance/CFO | 62 | 17-02-21 | |
Adam Levy
IRC | Investor Relations Contact | - | 01-11-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jaime Vieser
BRD | Director/Board Member | 54 | 16-12-20 |
Holger Weis
CHM | Chairman | 61 | 16-12-20 |
Robert Postma
BRD | Director/Board Member | 70 | 05-02-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.04% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,32 | +13,79% | 50 847 |
25-04-24 | 1,16 | -1,69% | 9 254 |
24-04-24 | 1,18 | -1,67% | 30 377 |
23-04-24 | 1,2 | +10,09% | 46 815 |
22-04-24 | 1,09 | -2,68% | 38 305 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+24,47% | 18,57 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |